Neurocysticercosis: Is serology useful in the absence of brain imaging?

Hector H. Garcia, Silvia Rodriguez, Robert H. Gilman, Armando E. Gonzalez, Victor C.W. Tsang

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

34 Citas (Scopus)


Neurocysticercosis (NCC) is endemic in most parts of the world and is now recognised as an important contributor to neurological disease. Serological diagnosis of NCC improved greatly in the past two decades and contributed to demonstrating previously unsuspected regions of endemicity. Claims for an accurate serological screening tool for human cysticercosis are frequently raised. However, after symptomatic therapeutics are applied, management of NCC is driven by the characteristics of the central nervous system infection in terms of viability, number, location size and evolutionary stage of parasites, as well as by the resulting inflammation. It is unclear whether, in the absence of neuroimaging, serological confirmation of aetiology of suspected cases (neurologically symptomatic) or detection of asymptomatic cases in population screening would affect their management or prognosis.

Idioma originalInglés
Páginas (desde-hasta)1014-1018
Número de páginas5
PublicaciónTropical Medicine and International Health
EstadoPublicada - ago. 2012
Publicado de forma externa


Profundice en los temas de investigación de 'Neurocysticercosis: Is serology useful in the absence of brain imaging?'. En conjunto forman una huella única.

Citar esto